Aijun J. Liao
No. 39 Huaxiang Street
Shenyang, 110021, China
Shenyang, 110021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis.
Journal: Journal of translational medicine
Published: May 24, 2026
Correction to: Methylation of SFRP5 is related to multidrug resistance in leukemia cells.
Journal: Cancer gene therapy
Published: April 13, 2026
Risk stratification, treatment patterns and survival outcomes in newly diagnosed multiple myeloma patients: A real-world analysis from the Chinese Myeloma Committee.
Journal: British journal of haematology
Published: February 11, 2026
Author Correction: Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma.
Journal: Nature communications
Published: December 19, 2025
Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025
Development and validation of a prognostic staging system for primary plasma cell leukemia.
Journal: Journal of hematology & oncology
Published: April 30, 2025
The role of complement in tumor immune tolerance and drug resistance: a double-edged sword.
Journal: Frontiers in immunology
Published: November 16, 2024
Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1.
Journal: Cancer
Published: July 16, 2024
Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma.
Journal: Nature communications
Published: April 17, 2024
Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia
Journal: Zhonghua yi xue za zhi
Published: February 06, 2024
Feature analysis of different neutrophil levels on the distribution of pathogens in bloodstream infection in patients with hematologic malignancy
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 04, 2023
Last Updated: 09/26/2026